Neobacitracine (Bacitracin, Neomycin)

Neobacitracine, the active ingredient in Neobacitracine, is a topical antibacterial presented as a topical preparation for auricular, cutaneous, nasal and ocular use. It treats bacterial infections of the outer ear, skin, nose and eye in patients who require localized therapy.

GNH USA supplies Neobacitracine as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Neobacitracine is a topical antibacterial that acts on Gram‑positive and Gram‑negative bacteria causing superficial infections.

- Outer ear infection: reduces bacterial load and promotes healing of otitis externa. - Skin infection: treats impetigo, minor abrasions and superficial bacterial dermatitis. - Nasal infection: clears bacterial colonisation in acute rhinitis or sinusitis. - Eye infection: helps resolve bacterial conjunctivitis and superficial keratitis.

Neobacitracine may cause local and systemic reactions, most of which are mild and reversible.

Common Side Effects: - Mild skin irritation or redness at the application site. - Itching or burning sensation where the product is applied. - Transient ear discomfort when used auricularly. - Nasal dryness or mild irritation. - Eye stinging or tearing. - Localized allergic contact dermatitis.

Serious or Rare Side Effects: - Anaphylactic reaction or severe systemic allergy. - Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Ototoxicity with prolonged ear use. - Nephrotoxicity after extensive systemic absorption. - Severe contact dermatitis with blistering. - Vision changes if ocular tissues are severely affected.

Before using Neobacitracine, consider the following safety measures.

- Allergy assessment: avoid in patients with known hypersensitivity to bacitracin or neomycin. - Pregnancy: safety not established; use only if potential benefit outweighs risk. - Breastfeeding: unknown safety; evaluate risk before use. - Application site: do not apply to large areas of broken skin to limit systemic absorption. - Concurrent ototoxic drugs: monitor for additive ear toxicity. - Store at room temperature: keep in original container, protect from moisture and light.

Neobacitracine can interact with other medicines; review the following categories.

Major Interactions (Avoid): - Systemic aminoglycosides: increased risk of nephrotoxicity and ototoxicity. - Topical ophthalmic anesthetics: may enhance corneal toxicity. - Other ototoxic agents: avoid concurrent use to prevent additive ear damage.

Moderate Interactions (Monitor Closely): - Topical corticosteroids: may mask signs of infection. - Heavy‑metal‑containing wound dressings: may reduce antibacterial efficacy. - Anticoagulants: monitor for rare bleeding if large skin areas are treated.